Analyst Ranking
Bottom 12%
#4238 out of 4792 analysts
Average Return
-1.43%
Win Rate
42%14 out of 33
Risk vs Reward
Poor
Good

Anne Samuel's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Waystar Holding CorpWAY
+74.20%$21.51$37.47
2024-07-01 -
2025-01-17
Strong Buy
Healthequity IncHQY
+46.33%$69.39$101.54
2023-11-30 -
2024-11-29
Strong Buy
Healthequity IncHQY
+41.69%$43.87$62.16
2021-12-20 -
2022-12-20
Strong Buy
Waystar Holding CorpWAY
+40.55%$26.66$37.47
2024-08-18 -
2025-01-17
Strong Buy
Phreesia IncPHR
+38.54%$19.64$27.21
2024-06-04 -
2025-01-17
Strong Buy

Anne Samuel Analyst Color

Get additional color on Anne Samuel's coverage of popular stocks

Anne Samuel's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Veeva Systems IncVEEV
5Hold$218.00+0.65%Maintains
a month ago
Progyny IncPGNY
6Hold$17.00-19.05%Downgrades
2 months ago
Evolent Health IncEVH
5Strong Buy$15.00+50.00%Maintains
2 months ago
Doximity IncDOCS
5Hold$48.00-10.65%Maintains
2 months ago
Omnicell IncOMCL
4Hold$44.00+3.36%Maintains
2 months ago
Iqvia Holdings IncIQV
5Strong Buy$240.00+21.61%Maintains
3 months ago
Phreesia IncPHR
2Strong Buy$28.00+2.90%Maintains
4 months ago
Premier IncPINC
4Hold$19.00-15.29%Maintains
4 months ago
Consensus Cloud Solutions IncCCSI
3Strong Sell$21.00-16.23%Downgrades
4 months ago
Health Catalyst IncHCAT
3Strong Buy$13.00+136.79%Maintains
5 months ago
Waystar Holding CorpWAY
2Strong Buy$27.00-27.94%Maintains
5 months ago
Definitive Healthcare CorpDH
1Strong Sell$5.00+26.90%Downgrades
6 months ago
Healthequity IncHQY
4Strong Buy$108.00+5.45%Maintains
10 months ago
R1 Rcm IncRCM
3Hold$11.00N/ADowngrades
a year ago
Model N IncMODN
1Hold$25.00N/ADowngrades
a year ago
Veradigm IncMDRX
1Strong Sell$20.00N/AMaintains
2 years ago
Signify Health IncSGFY
2Hold$30.50N/ADowngrades
2 years ago
Convey Health Solutions Holdings IncCNVY
1Hold$12.00N/AInitiates Coverage On
4 years ago
Heliogen IncHLGN
1Hold$159.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.